Be part of the knowledge.™

Cardiology

2207

LikeLikedUnlike

Episodes 121-135 of 845

No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action Center
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
- Javed Butler, MD
  Peer
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Heart Matters
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
- Javed Butler, MD
  Peer
- Jeffrey Wilson, MD
  Peer
Active Aging: Preventing Heart Failure in Older Women with Exercise
Heart Matters
Active Aging: Preventing Heart Failure in Older Women with Exercise
- Javed Butler, MD
  Peer
- Michael J. LaMonte, PhD, MPH
  Peer
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Clinician's Roundtable
Improving CKD Patient Outcomes with SGLT2 Inhibitors
- Gates B. Colbert, MD
  Peer
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
Heart Matters
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart Matters
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
advertisement
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Heart Matters
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
- Javed Butler, MD
  Peer
- Chiadi Ndumele, M.D., Ph.D., M.H.S.
  Peer
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Heart Matters
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
Heart Matters
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Dave L. Dixon, PharmD, FACC, FCCP, FNLA, BCPS, BCACP, CDE, CLS
  Peer
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
Heart Matters
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
Learning About the New Definition of MASLD
GI Insights
Learning About the New Definition of MASLD
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- Paul Kwo, MD
  Peer
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Heart Matters
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Javed Butler, MD
  Peer
advertisement
A Discussion on Statins to Lower CVD Risk for HIV Patients
Heart Matters
A Discussion on Statins to Lower CVD Risk for HIV Patients
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Steve Grinspoon, MD
  Peer
Increasing BP Control with the AMA MAP™ Hypertension Program
Perspectives with the AMA
Increasing BP Control with the AMA MAP™ Hypertension Program
- Jennifer Caudle, DO
  Peer
- Chantal Tinfang, MD
  Peer
- Kesha Love, MSN, RN
  Peer
A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults
Heart Matters
A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended